Tci Wealth Advisors, Inc. Abb Vie Inc. Call Options Transaction History

Tci Wealth Advisors, Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $562,650 - $619,410	-5,500 Reduced 55.0%	4,500 $487,000
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $402,450 - $543,350	5,000 Added 100.0%	10,000 $1.07 Million
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $429,550 - $504,150	5,000 New	5,000 $438,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.